Multiparametric ultrasound evaluation of liver fibrosis, steatosis, and viscosity in patients with chronic liver disease.

Autor:	Minciuna I; Regional Institute of Gastroenterology and Hepatology ''O. Fodor'', 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca. iuliabreaban@yahoo.com., Taru M; Regional Institute of Gastroenterology and Hepatology ''O. Fodor'', 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca., Fodor A; Regional Institute of Gastroenterology and Hepatology ''O. Fodor'', Cluj-Napoca., Nicoara Farcau O; Regional Institute of Gastroenterology and Hepatology ''O. Fodor'', 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca., Fischer P; Regional Institute of Gastroenterology and Hepatology ''O. Fodor'', 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca., Radu C; Regional Institute of Gastroenterology and Hepatology ''O. Fodor'', 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca., Lupsor-Platon M; Regional Institute of Gastroenterology and Hepatology ''O. Fodor'', 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca., Stefanescu H; Regional Institute of Gastroenterology and Hepatology ''O. Fodor'', Cluj-Napoca., Procopet B; Regional Institute of Gastroenterology and Hepatology ''O. Fodor'', 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca.
Jazyk:	angličtina
Zdroj:	Medical ultrasonography [Med Ultrason] 2024 Jun 21; Vol. 26 (2), pp. 117-124. Date of Electronic Publication: 2024 Feb 27.
DOI:	10.11152/mu-4327
Abstrakt:	Aims: This study assessed the effectiveness of three ultrasound-based techniques (2D-SWE.PLUS, Att.PLUS, Vi.PLUS) for non-invasive evaluation of liver fibrosis, steatosis, and inflammation in chronic liver disease (CLD) patients.Materials and methods: Involving 209 consecutive compensated CLD patients, the study compared these ultrasound methods from Aixplorerwith standard Vibration-controlled Transient Elastography (VCTE) and Controlled Attenuation Parameter (CAP) from Fibroscan, alongside non-invasive serological markers. Results: High validity rates were observed in measurements: 99% for VCTE, 89% for 2D-SWE.PLUS/Vi.PLUS, and 96.6% for Att.PLUS. 2D-SWE.PLUS showed a strong correlation with VCTE (R=0.91) and excelled at a lower Stability Index (80%), with optimal cut-offs for moderate and severe fibrosis at 8 kPa and 10 kPa, respectively. 2D-SWE.PLUS was superior to Fib4, eLIFT, APRI, BARD, and NFS in detecting advanced CLD. Att.PLUS moderately correlated with CAP (R=0.47) for steatosis grades, while Viscosity was highly effective in identifying significant fibrosis (AUC=0.87) but less so for inflammation. Conclusions: 2D-SWE.PLUS demonstrated superior diagnostic precision in liver fibrosis, exceeding other non-invasive markers. Att.PLUS was relatively accurate for liver steatosis, and viscosity more effectively indicated fibrosis stages than inflammation in CLD patients.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu PDF